Docmode Health Technologies Ltd.
•₹ 31.45-4.98%
2026-08-21
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 20.4%
- Working capital cycle has improved - days down from 41 to -38
CONS
- Company is loss-making at the operating / net level
- Interest coverage is weak at -0.0x - earnings barely cover interest
- Operating margins have contracted to -1.6% from 15.3%
- Inventory has been piling up - inventory days up from 23 to 60
- Company's return on assets is weak at -5.9%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | PWL | 121.95 | 1735.41 | 35376.31 | 0.00 | -882.80 | -595.06 | 10539.50 | 1144.20 | -17.62 | -5.41 |
| 2. | SEIL | 210.15 | 582.14 | 3383.41 | 0.00 | 2.82 | -2.76 | 16.30 | 7.51 | 14.21 | 26.28 |
| 3. | CRIZAC | 171.60 | 13.62 | 3002.70 | 4.66 | 46.17 | 0.77 | 201.21 | -3.97 | 52.73 | 30.40 |
| 4. | VERANDA | 255.00 | 17.03 | 2456.95 | 0.00 | 33.87 | 467.88 | 149.54 | 7.37 | 22.75 | 35.96 |
| 5. | JARO | 439.60 | 25.77 | 979.01 | 1.14 | 11.17 | 48.33 | 70.75 | 16.60 | 25.32 | 21.43 |
| 6. | GLOBAL | 106.29 | 20.75 | 541.03 | 0.94 | 3.75 | -11.05 | 14.21 | -4.15 | 29.17 | 41.68 |
| 7. | CPEDU | 203.00 | 15.48 | 369.32 | 0.00 | 8.08 | 12.54 | 14.35 | -1.17 | 40.71 | 64.15 |
| 8. | CPCAP | 122.60 | 4.94 | 223.05 | 0.00 | 13.31 | 23.50 | 21.95 | 47.39 | 9.83 | 93.11 |
| 9. | VIRTUALG | 0.53 | 0.00 | 30.01 | 0.00 | 0.07 | 133.33 | 0.26 | — | -0.46 | 32.57 |
| 10. | TREEHOUSE | 6.19 | 0.00 | 26.19 | 0.00 | -2.13 | -233.00 | 1.15 | -20.14 | -6.84 | -212.70 |
| 11. | DHTL | 33.10 | 0.00 | 10.40 | 0.00 | — | — | — | — | -0.27 | — |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 7 | 12 | 33 | 40 | 42 | |
| 6 | 11 | 29 | 38 | 42 | |
| Operating Profit | 1 | 2 | 4 | 2 | 0 |
| OPM % | 12 | 15 | 12 | 5 | 1 |
| Other Income | 0 | 0 | 0 | 0 | 1 |
| Interest | 0 | 0 | 1 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| 1 | 2 | 3 | 0 | -2 | |
| Tax % | 14 | 38 | 28 | 44 | -3 |
| Net Profit | 1 | 1 | 2 | 0 | -2 |
| EPS | 555 | 8 | 8 | 1 | -6 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 3 | 5 | 8 | 1 | -6 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 3 | 5 | 8 | 1 | -6 |
Mar 2021
- 7
- 6
- Operating Profit
- 1
- OPM %
- 12
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 14
- Net Profit
- 1
- EPS
- 555
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2022
- 12
- 11
- Operating Profit
- 2
- OPM %
- 15
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 2
- Tax %
- 38
- Net Profit
- 1
- EPS
- 8
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2023
- 33
- 29
- Operating Profit
- 4
- OPM %
- 12
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- 3
- Tax %
- 28
- Net Profit
- 2
- EPS
- 8
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
Mar 2024
- 40
- 38
- Operating Profit
- 2
- OPM %
- 5
- Other Income
- 0
- Interest
- 2
- Depreciation
- 0
- 0
- Tax %
- 44
- Net Profit
- 0
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2025
- 42
- 42
- Operating Profit
- 0
- OPM %
- 1
- Other Income
- 1
- Interest
- 2
- Depreciation
- 0
- -2
- Tax %
- -3
- Net Profit
- -2
- EPS
- -6
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -6
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 50%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -32%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 56%
- 3 Years:
- 20%
- Last Year:
- -22%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - |
| Equity Capital | 0 | 0 | 2 | 3 | 3 |
| 0 | 1 | 1 | 7 | 5 | |
| 0 | 0 | 1 | 1 | 3 | |
| Trade Payables | 3 | 2 | 3 | 3 | 5 |
| 3 | 7 | 9 | 16 | 23 | |
| Total Liabilities | 6 | 10 | 17 | 30 | 39 |
| ASSETS | - | - | - | - | - |
| 0 | 0 | 0 | 1 | 1 | |
| 0 | 1 | 1 | 1 | 1 | |
| 3 | 3 | 3 | 3 | 11 | |
| 0 | 0 | 0 | 11 | 9 | |
| Cash & Bank | 0 | 0 | 0 | 3 | 2 |
| 2 | 6 | 13 | 11 | 14 | |
| Total Assets | 6 | 10 | 17 | 30 | 39 |
| Total Debt | 1 | 5 | 8 | 9 | 7 |
| Net Working Capital | 1 | 3 | 5 | 4 | -4 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 466.50 | 1390.50 | 15.17 | 33.04 | 26.58 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 1 | 5 | 8 | 9 | 7 |
| Net Working Capital | 1 | 3 | 5 | 4 | -4 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 466.50 | 1390.50 | 15.17 | 33.04 | 26.58 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2021
- Equity Capital
- 0
- 0
- 0
- Trade Payables
- 3
- 3
- Total Liabilities
- 6
- 0
- 0
- 3
- 0
- Cash & Bank
- 0
- 2
- Total Assets
- 6
- Total Debt
- 1
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 466.50
- Face Value
- 10.00
- Total Debt
- 1
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 466.50
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 0
- 1
- 0
- Trade Payables
- 2
- 7
- Total Liabilities
- 10
- 0
- 1
- 3
- 0
- Cash & Bank
- 0
- 6
- Total Assets
- 10
- Total Debt
- 5
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 1390.50
- Face Value
- 10.00
- Total Debt
- 5
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 1390.50
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 2
- 1
- 1
- Trade Payables
- 3
- 9
- Total Liabilities
- 17
- 0
- 1
- 3
- 0
- Cash & Bank
- 0
- 13
- Total Assets
- 17
- Total Debt
- 8
- Net Working Capital
- 5
- Contingent Liabilities
- 0
- Book Value per Share
- 15.17
- Face Value
- 10.00
- Total Debt
- 8
- Net Working Capital
- 5
- Contingent Liabilities
- 0
- Book Value per Share
- 15.17
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 3
- 7
- 1
- Trade Payables
- 3
- 16
- Total Liabilities
- 30
- 1
- 1
- 3
- 11
- Cash & Bank
- 3
- 11
- Total Assets
- 30
- Total Debt
- 9
- Net Working Capital
- 4
- Contingent Liabilities
- 0
- Book Value per Share
- 33.04
- Face Value
- 10.00
- Total Debt
- 9
- Net Working Capital
- 4
- Contingent Liabilities
- 0
- Book Value per Share
- 33.04
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 3
- 5
- 3
- Trade Payables
- 5
- 23
- Total Liabilities
- 39
- 1
- 1
- 11
- 9
- Cash & Bank
- 2
- 14
- Total Assets
- 39
- Total Debt
- 7
- Net Working Capital
- -4
- Contingent Liabilities
- 0
- Book Value per Share
- 26.58
- Face Value
- 10.00
- Total Debt
- 7
- Net Working Capital
- -4
- Contingent Liabilities
- 0
- Book Value per Share
- 26.58
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| -0 | -2 | -1 | 4 | 7 | |
| Cash from Investing | -0 | -2 | -2 | -8 | -4 |
| Cash from Financing | 1 | 3 | 3 | 6 | -4 |
| 0 | -0 | 0 | 3 | -1 | |
| Free Cash Flow | -0 | -2 | -1 | 4 | 6 |
| OCF / Net Profit | -0.90 | -2.22 | -0.43 | 23.17 | -3.27 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
| OCF / Net Profit | -0.90 | -2.22 | -0.43 | 23.17 | -3.27 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
Mar 2021
- -0
- Cash from Investing
- -0
- Cash from Financing
- 1
- 0
- Free Cash Flow
- -0
- OCF / Net Profit
- -0.90
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.90
- Cumulative 5-Year FCF
- 0
Mar 2022
- -2
- Cash from Investing
- -2
- Cash from Financing
- 3
- -0
- Free Cash Flow
- -2
- OCF / Net Profit
- -2.22
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -2.22
- Cumulative 5-Year FCF
- 0
Mar 2023
- -1
- Cash from Investing
- -2
- Cash from Financing
- 3
- 0
- Free Cash Flow
- -1
- OCF / Net Profit
- -0.43
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.43
- Cumulative 5-Year FCF
- 0
Mar 2024
- 4
- Cash from Investing
- -8
- Cash from Financing
- 6
- 3
- Free Cash Flow
- 4
- OCF / Net Profit
- 23.17
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 23.17
- Cumulative 5-Year FCF
- 0
Mar 2025
- 7
- Cash from Investing
- -4
- Cash from Financing
- -4
- -1
- Free Cash Flow
- 6
- OCF / Net Profit
- -3.27
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -3.27
- Cumulative 5-Year FCF
- 0
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - |
| EPS (₹) | 554.60 | 923.90 | 8.50 | 0.62 | -6.46 |
| Book Value (₹) | 466.50 | 1390.50 | 15.17 | 33.04 | 26.58 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 3.36 | 5.39 | 8.59 | 0.69 | -5.51 |
| PROFITABILITY | - | - | - | - | - |
| Operating Margin % | 12.29% | 15.31% | 11.68% | 4.72% | -1.65% |
| Net Margin % | 7.81% | 7.44% | 5.93% | 0.48% | -4.86% |
| ROE % | 118.89% | 99.50% | 80.03% | 2.79% | -21.68% |
| ROCE % | 55.01% | 48.45% | 42.01% | 12.68% | -0.33% |
| 9.85% | 11.81% | 14.50% | 0.83% | -5.88% | |
| EFFICIENCY | - | - | - | - | - |
| Debtor Days | 70 | 76 | 67 | 90 | 90 |
| Inventory Days | 168 | 85 | 28 | 23 | 60 |
| Payable Days | 513 | 484 | 918 | 364 | -235 |
| -274 | -323 | -822 | -251 | 386 | |
| FINANCIAL HEALTH | - | - | - | - | - |
| Debt to Equity (x) | 2.26x | 3.48x | 2.44x | 0.88x | 0.82x |
| Interest Coverage (x) | 4.36x | 5.00x | 3.38x | 1.21x | -0.03x |
| 1.23x | 1.69x | 1.58x | 1.30x | 0.85x | |
| GROWTH | - | - | - | - | - |
| Revenue Growth % | 0.00% | 74.95% | 164.66% | 21.68% | 4.41% |
| Operating Profit Growth % | 0.00% | 117.82% | 102.02% | -47.36% | -88.08% |
| Net Profit Growth % | 0.00% | 66.59% | 110.92% | -90.06% | -1148.74% |
| 0.00% | 0.00% | 0.00% | -92.75% | -1148.74% | |
| VALUATION | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 346.73x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 6.47x | 1.86x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 36.22x | 85.41x |
Mar 2021
- EPS (₹)
- 554.60
- Book Value (₹)
- 466.50
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.36
- Operating Margin %
- 12.29%
- Net Margin %
- 7.81%
- ROE %
- 118.89%
- ROCE %
- 55.01%
- 9.85%
- Debtor Days
- 70
- Inventory Days
- 168
- Payable Days
- 513
- -274
- Debt to Equity (x)
- 2.26x
- Interest Coverage (x)
- 4.36x
- 1.23x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 923.90
- Book Value (₹)
- 1390.50
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5.39
- Operating Margin %
- 15.31%
- Net Margin %
- 7.44%
- ROE %
- 99.50%
- ROCE %
- 48.45%
- 11.81%
- Debtor Days
- 76
- Inventory Days
- 85
- Payable Days
- 484
- -323
- Debt to Equity (x)
- 3.48x
- Interest Coverage (x)
- 5.00x
- 1.69x
- Revenue Growth %
- 74.95%
- Operating Profit Growth %
- 117.82%
- Net Profit Growth %
- 66.59%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 8.50
- Book Value (₹)
- 15.17
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.59
- Operating Margin %
- 11.68%
- Net Margin %
- 5.93%
- ROE %
- 80.03%
- ROCE %
- 42.01%
- 14.50%
- Debtor Days
- 67
- Inventory Days
- 28
- Payable Days
- 918
- -822
- Debt to Equity (x)
- 2.44x
- Interest Coverage (x)
- 3.38x
- 1.58x
- Revenue Growth %
- 164.66%
- Operating Profit Growth %
- 102.02%
- Net Profit Growth %
- 110.92%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 0.62
- Book Value (₹)
- 33.04
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.69
- Operating Margin %
- 4.72%
- Net Margin %
- 0.48%
- ROE %
- 2.79%
- ROCE %
- 12.68%
- 0.83%
- Debtor Days
- 90
- Inventory Days
- 23
- Payable Days
- 364
- -251
- Debt to Equity (x)
- 0.88x
- Interest Coverage (x)
- 1.21x
- 1.30x
- Revenue Growth %
- 21.68%
- Operating Profit Growth %
- -47.36%
- Net Profit Growth %
- -90.06%
- -92.75%
- P/E (x)
- 346.73x
- P/B (x)
- 6.47x
- Dividend Yield %
- 0.00%
- 36.22x
Mar 2025
- EPS (₹)
- -6.46
- Book Value (₹)
- 26.58
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -5.51
- Operating Margin %
- -1.65%
- Net Margin %
- -4.86%
- ROE %
- -21.68%
- ROCE %
- -0.33%
- -5.88%
- Debtor Days
- 90
- Inventory Days
- 60
- Payable Days
- -235
- 386
- Debt to Equity (x)
- 0.82x
- Interest Coverage (x)
- -0.03x
- 0.85x
- Revenue Growth %
- 4.41%
- Operating Profit Growth %
- -88.08%
- Net Profit Growth %
- -1148.74%
- -1148.74%
- P/E (x)
- 0.00x
- P/B (x)
- 1.86x
- Dividend Yield %
- 0.00%
- 85.41x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.